[Analeptic cardiorespiratory properties of the combination of 2-ethyl-3,3-diphenyl-propen-(2)-yl-amine-gluconate and heptaminol chlorhydrate].
D000605:Amino Alcohols / Q000008:administration & dosage* / Q000633:toxicity; D000818:Animals; D001463:Barbiturates / Q000037:antagonists & inhibitors; D001794:Blood Pressure / Q000187:drug effects*; D002339:Carotid Arteries; D002415:Cats; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003864:Depression, Chemical; D004231:Diuresis / Q000187:drug effects*; D004285:Dogs; D004357:Drug Synergism; D005942:Gluconates / Q000008:administration & dosage* / Q000633:toxicity; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D009929:Organ Size; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects*; D013268:Stimulation, Chemical
D000605:Amino Alcohols; D001463:Barbiturates; D000697:Central Nervous System Stimulants; D005942:Gluconates
Propriétés analeptiques cardiorespiratoires de l'association 2-ethyl-3,3-diphényl-propéne-(2)-yl-amine-gluconate--chlorhydrate d'heptaminol.